Monday, 26 October 202611:25 pm ISTIndia edition

सच, सीधे आप तक

Book ad space

Just in

Health

Sitagliptin-Based Triple FDC Achieves Greater HbA1c Reduction Than Metformin Plus Glimepiride in Indian Diabetics: Study

Image: Business Medical Dialogues. Rights remain with the publisher.

A new study published in the journal of Diabetes Obesity and Metabolism showed that a triple fixed-dose combination containing sitagliptin provides a larger reduction in HbA1c levels when compared to...

Read the full report on Business Medical Dialogues

Story file

Section
Health
Topics
Health alerts
First reported by
Business Medical Dialogues
Reporter
jacinthlyn sylvia
Published
Monday, 26 October 2026, 9:15 am IST
Coverage
One outlet so far

How this page works. The Headline Update lists this report from Business Medical Dialogues with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.

Related stories

More Health news

See all